肺癌
糖尿病
基因
癌症
肿瘤科
肺
医学
内科学
生物
遗传学
内分泌学
作者
Jincheng Yang,N. Li,Weilong Lin,Ming Deng,Liming Shi,An Yu,Juan Yang,Chengcheng Zhou,Qin Tong,Wenjing Yang
出处
期刊:Current Cancer Drug Targets
[Bentham Science]
日期:2023-05-31
卷期号:23 (11): 889-899
被引量:1
标识
DOI:10.2174/1568009623666230529154306
摘要
Diabetes mellitus (DM) is a major public health problem worldwide. Cancer is the second most common cause of death in the United States and the leading cause of death in China. There is compelling evidence that individual risk for type 2 diabetes mellitus (T2DM) is strongly influenced by genetic factors. DM and cancer may interact with one another; some kinds of cancer accompany DM, and DM can also promote cancer.An analysis was conducted of diabetes mellitus-related gene (DM-gene) expression levels in tumor and normal tissues, clinical parameters, tumor stages, mutations, copy number variations (CNVs), immune cell infiltration, survival, gene enrichment, and gene ontology annotations.This analysis revealed six genes that appear to play key roles in lung cancer survival: MTMR3 (in lung adenocarcinoma [LUAD]) and COBLL1, PPARG, PPIP5K2, RREB1, and WFS1 (in lung squamous cell carcinoma [LUSC]).The results suggested that clinical practitioners and researchers should account for PPARG and RREB1 expression when selecting or testing chemotherapy drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI